share_log

Scopus BioPharma | PRER14A: Preliminary revised proxy soliciting materials

SEC ·  Jun 29, 2023 05:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more